| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9595 |
| Human Intestinal Absorption | HIA+ | 0.9962 |
| Caco-2 Permeability | Caco2+ | 0.5891 |
| P-glycoprotein Substrate | Substrate | 0.8469 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8727 |
| Non-inhibitor | 0.8955 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.5259 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6252 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7851 |
| CYP450 2D6 Substrate | Substrate | 0.8919 |
| CYP450 3A4 Substrate | Substrate | 0.5897 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7611 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8586 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.5881 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7452 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8234 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5501 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8713 |
| Non-inhibitor | 0.6608 |
| AMES Toxicity | Non AMES toxic | 0.7817 |
| Carcinogens | Non-carcinogens | 0.9618 |
| Fish Toxicity | High FHMT | 0.6607 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9363 |
| Honey Bee Toxicity | High HBT | 0.5198 |
| Biodegradation | Not ready biodegradable | 0.9975 |
| Acute Oral Toxicity | II | 0.5114 |
| Carcinogenicity (Three-class) | Non-required | 0.5685 |